Clinical trial
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
NCT00035867 · Telik, Industry · Completed
Key facts
| NCT number | NCT00035867 |
|---|---|
| Title | Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome |
| Official title | Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome |
| Lead sponsor | Telik, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | TLK199 HCl Liposomes for Injection |
| Enrollment | 65 |
| Start date | Apr 1, 2002 |
| Completion | May 1, 2007 |
| First posted | May 7, 2002 |
| Last update posted | Jun 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: